EpimAb Biotherapeutics Welcomes Dr. Yonghong Zhu as Chief Medical Officer: A Strategic Move Towards Business Success
EpimAb Biotherapeutics Appoints Yonghong Zhu, M.D., Ph.D., as Chief Medical Officer Exciting Growth for EpimAb Biotherapeutics EpimAb Biotherapeutics, a leading biotechnology company based in Shanghai, China, recently announced a significant milestone with the appointment of Dr. Yonghong Zhu as Chief Medical Officer (CMO). Dr. Zhu brings with him a wealth of experience and expertise in…